The key risk is balance-sheet gravity: high-cost notes and limited cash buffer can force
dilution or constrain product investment. Next is cyber-physical reliability—one major control/security incident could trigger churn, liability, and reputational damage. Finally, competition (integrators, OEM-native stacks, industrial automation vendors) can commoditize
EMS/optimization unless Stem proves measurable savings and locks in long-lived renewals.